Skip to main content

CEO/Founder's Story

Allison L. Watkins, the visionary entrepreneur behind Yōni.Fit, experienced the challenges of SUI after becoming a mother. Frustrated by the limited options available, she embarked on a mission to design a solution that she hopes will transform the lives of millions of women worldwide.

Meet Our Team

Our team is comprised of genuinely gifted minds

Kate C Arnold, MD, MBA

Chief Medical Officer

Dr. Kate C Arnold, MD, MBA is a board-certified OBGYN with expertise in women’s health - from surgery to biomedical intervention to technology-enabled care. She is passionate about addressing maternal health and disparities of care in underserved populations. Dr. Arnold received a bachelors from Santa Clara University, a Doctor of Medicine degree from Georgetown University, and an MBA in healthcare administration from Oklahoma City University. Dr. Arnold has held leadership roles with the American College of Obstetricians and Gynecologists (ACOG), and currently serves on the Maternal Care Professionals Advisory Committee under the Washington D.C. Board of Medicine.

Ross Watkins

President

Ross is the President of Watkins-Conti where he brings extensive expertise in strategy and negotiations. Ross began his career out of college at a Fortune 500 metals and recycling in new steel sales. Ross was later promoted to purchasing and eventually landed with the National Accounts Division. From there, he transitioned into the oil and gas and commercial real estate industry. Ross’ passion led him back to the metals industry where he founded RAARE Metal Concepts in 2010 which now extends its operation through 33 states and multiple countries. Watkins’ next venture began in 2015 with Big Box Waste, a waste disposal company. In 2017, Watkins acquired a software development company. Ross graduated from Texas Tech University in 2001 with a bachelor degree in marketing.

Allison Watkins

Founder | CEO

Allison founded Watkins-Conti Products, Inc. in 2016 to pioneer solutions for women’s pelvic health. Following the birth of her children, she experienced stress urinary incontinence (SUI), the involuntary leakage of urine when exerting pressure on the bladder during physical activity. Frustrated by the limited options, she engineered, patented, and manufactured Yōni.Fit, a comfortable and convenient device for the management of SUI. Yōni.Fit is pending FDA approval following completion of a national clinical trial by Urogynecologists at Stanford, NYU, and Jefferson Health.

Allison has raised funds from private investors to create quality management systems, a robust intellectual property portfolio, secure contract manufacturing, conduct clinical trials, and expand her executive team and expert advisers.

An engaging speaker, Allison challenges social taboos around women’s health and well-being. She is passionate about developing treatments that benefit women, and funding for women-led healthcare companies. Allison was recognized in Business Times’ Top 20 under 40, Disrupt magazine’s Top Ten Influential Women, and the Journal Record’s Achievers Under 40.

Amber Hilfiger

Quality Manager

Amber brings to Watkins-Conti Products more than 15 years’ experience in quality compliance for medical device manufacturing. As the former Director of Operations for a consulting firm focused on medical device quality, regulatory, and microbiology, she has led dozens of clients of all sizes through various aspects of managing quality systems and providing quality support for regulatory submissions and audits both domestic and international. Amber manages the effort to ensure the safety and effectiveness of Watkins-Conti products through quality system implementation and maintenance and premarket and postmarket activities including verification/validation, supplier management, management controls, corrective and preventive action, etc. Amber has a B.S.E. in Biomedical Engineering from Tulane University in New Orleans, and an M.S.E. in Engineering Management from the University of Texas at Austin. Amber holds certifications as an ASQ Certified Quality Auditor (CQA) and an ASQ Certified Quality Technician (CQT).

Brooke Wigley

Director of Operations

Brooke oversees the day-to-day financial and operational functions of the business. She works closely with the CEO to implement policies and procedures in support of company growth plans. Brooke originally joined the company in 2016, and brings over 20 years of related experience. She began her career as an accountant for a restaurant franchise, where she managed payroll and accounting. Prior to that, she worked as an independent bookkeeper for local businesses. Brooke holds a degree in accountancy from Western Governors University and is a notary public.

Nada Hanafi

Regulatory Strategy

Nada advises the company on regulatory strategy and assists the CEO as she prepares for FDA submissions. She also serves as Senior Vice President of Regulatory Strategy at Veranex where she oversees the regulatory team by supporting clients with setting strategic direction, evidence pipeline, and all aspects of design, development, commercial distribution of devices, and postmarket compliance to ensure products remain safe and effective while on the market. A results-oriented executive with over 20 years of experience advising CEOs and Founders in the MedTech and life-sciences industry. Hanafi spent over 12.5 years at FDA’s Center for Devices and Radiological Health (CDRH) working on a range of products from breast implants to neurological devices, and co-founded the CDRH Health of Women Program. Nada holds an MSc. in Biomaterials and a BEng in Biomedical Materials Science & Engineering from Queen Mary College, University of London. She earned an MPH from Johns Hopkins Bloomberg School of Public Health. Nada is a Certified Quality Improvement Associate and a Certified Quality Auditor from the American Society for Quality.

Dr. Anula Jayasuriya, MD, PhD, MBA

Founder and Managing Director EXXclaim Capital, Co-Founder EILSF

Anula is the founder of EXXclaim Capital, an early-stage venture fund focused on catalyzing innovation, entrepreneurship, and investment in Women’s Health. She also co-founded EILSF, the first Indian fund focusing on health care. A successful venture capitalist, her background combines deep business, scientific and medical knowledge with broad clinical, industry, entrepreneurial, and investment experience. She sits on several private biotech boards and the board of the public company, LCTX. Previously, Anula was an investor at Skyline Ventures and TVM, VP Business Development at Genomics Collaborative Inc., and Vice President, Global Drug Development at Hoffman-La Roche. Anula received her BA from Harvard summa cum laude, and an MD and PhD from Harvard Medical School. She interned in Pediatrics at Boston Children’s Hospital and earned an MBA with distinction from Harvard Business School.

Karolynn Echols, MD, FACOG, FURPS, Dip ABOIM

Founder and Managing Director EXXclaim Capital, Co-Founder EILSF

Dr. Karolynn Echols is Associate Professor, section chief of Urogynecology and Reconstructive Pelvic Surgery at Thomas Jefferson University Hospital and co-director of the Jefferson Comprehensive Urogynecology and Female Pelvic Medicine program. She earned her bachelor’s degree in electrical engineering from Cornell University, most recently completed a fellowship in Integrative Medicine and is board certified in the field. She is currently the only board-certified Urogynecologist that is board certified in Integrative Medicine in the world. She is also certified in Japanese acupuncture and incorporates this into her unique practice. She is recognized as an expert in all aspects of Urogynecology including the conventional, surgical, and complementary management of pelvic organ prolapse, urinary incontinence, menopause, sexual health, and pelvic pain and takes an integrative approach to all patients. She is widely published and currently concentrating her research on Integrative Urogynecology and Regenerative Medicine as it applies to women’s health, more specifically urinary incontinence, pelvic reconstructive surgery, perimenopause, sexual health, and pain and has patents pending in this arena. She was one of the principal investigators of the successful clinical trial of the Yoni-Fit device developed for stress urinary incontinence that has just been FDA approved for prescription. She is also an expert in the integrative treatment of menopause and perimenopause and was recently interviewed on FOX 29 Philadelphia on the subject.

Dr. Echols also has vast experience doing philanthropic work in obstetrical fistula, urogynecologic surgery and gynecology in Cameroon, Niger, Kenya, Rwanda, and Jamaica. She has been a board member of the International Organization of Women and Development and a genitourinary fistula mission Team Lead to Niger and Rwanda for several years. Currently, she is the president and co-founder of Medicine in Action, a non-profit organization that continues to enhance women and children’s health in Jamaica since 2005. Dr. Echols has been an honorary consultant for the University of West Indies in Kingston, Jamaica where she teaches residents, faculty and students and continues to lead Female Pelvic Medicine and Reconstructive Surgery (Urogynecology) surgical missions biannually. She has received numerous teaching awards and has been frequently awarded “Top Doc” in SJ, South Jersey Magazine since 2007 and most recently Philadelphia Magazine by Castle Connolly annually since 2018.

During the pandemic, she successfully helped establish some important DEI initiatives for the department of OB/Gyn at Jefferson and currently serves as Award Committee liaison of the DEI Committee of the American Urogynecologic Society. She is the first Urogynecologist to serve on the written board committee of the American Board of Integrative Medicine and was recently nominated and elected to volunteer on the Board itself.